OraSure Technologies, Inc. announced the launch of its HEMAcollect™●PROTEIN product, developed by its subsidiary DNA Genotek. This novel evacuated blood collection tube (BCT) is designed to meet the evolving needs of proteomic researchers.
The HEMAcollect™●PROTEIN BCT features proprietary stabilizing liquid that preserves plasma proteins in whole blood for up to seven days, facilitating storage and transport at ambient temperature. This addresses a key limitation of general blood collection tubes, which often require cold chain logistics.
Currently available for research use only, this product aims to deliver operational and financial efficiencies to proteomic researchers and support the generation of high-quality data. It is compatible with a broad range of proteomic technologies, including mass spectrometry and immunoassays, enabling research in areas like oncology, neurology, and cardiology.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.